Stock A249420 ILDONG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ildong Pharmaceutical Co., Ltd.

Equities

A249420

KR7249420001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
14,870 KRW +0.61% Intraday chart for Ildong Pharmaceutical Co., Ltd. +3.26% -18.12%
2023 Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea MT
2023 Il Dong Pharmaceutical Introduces New R&D Unit Yunovia MT

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Ildong Pharmaceutical Co., Ltd.

Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea MT
Il Dong Pharmaceutical Introduces New R&D Unit Yunovia MT
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 30 billion in funding CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 30 billion in funding CI
Ildong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Il Dong's Application for Shionogi's COVID Oral Medication Accepted for Review in South Korea MT
Ildong Pharmaceutical Co., Ltd. Files a New Drug Application with the MFDS for the Indication of SARS-CoV-2 Infection, and This Application Has Been Accepted for Review by MFDS CI
Shionogi JV Sub-licenses COVID-19 Drug to South Korea's Il Dong Pharmaceutical MT
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology MT
Twist Bioscience Corporation and Ildong Pharmaceutical Enter into Collaboration to Enhance Antibody Discovery for Applications in Immuno-Oncology CI
South Korean Pharmaceutical Firms Rush to Develop COVID-19 Oral Pills MT
Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug MT
Ildong Pharmaceutical Starts Phase 1 Study of New Diabetes Therapy in Germany CI
Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 100 billion in funding CI
Ildong Pharmaceutical Co., Ltd. announced that it expects to receive KRW 100 billion in funding CI
Evotec SE and Ildong to Collaborate with Development Projects on Indigo Platform CI
Ildong Pharmaceutical Co., Ltd. Enters into Co-Promotion Agreement with GSK Consumer Healthcare SA CI
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion. CI
AntriaBio, Inc. announced that it has received $13 million in funding from Aju Pharm Co Limited, Ildong Pharmaceutical Co., Ltd., Medici Investment CI
Ildong Holdings Co., Ltd. completed the acquisition of 19.25% stake in Ildong Pharmaceutical Co., Ltd. for KRW 65.4 billion. CI
AntriaBio, Inc. announced that it expects to receive $15 million in funding CI
Ildong Holdings Co., Ltd. made a tender offer to acquire an additional 29.14% stake in Ildong Pharmaceutical Co., Ltd. for KRW 98.9 billion. CI
Ildong Pharmaceutical Co., Ltd. completed the Spin-Off of its pharmaceutical business division for KRW 518.3 billion. CI
Ildong Pharmaceutical Co., Ltd. agreed to spin-off its pharmaceutical business division. CI
Ildong Holdings Co., Ltd. cancelled the Spin-Off of Ildong Pharmaceutical Co., Ltd.. CI

Chart Ildong Pharmaceutical Co., Ltd.

Chart Ildong Pharmaceutical Co., Ltd.
More charts

Company Profile

IL DONG PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
2024-05-12 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ILDONG PHARMACEUTICAL CO., LTD. Stock Ildong Pharmaceutical Co., Ltd.
-18.12% 302M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.01% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.28% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.50% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.19% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.72% 196B
PFIZER, INC. Stock Pfizer, Inc.
-10.65% 149B
AMGEN INC. Stock Amgen Inc.
-6.55% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A249420 Stock
  4. News Ildong Pharmaceutical Co., Ltd.
  5. Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug